HP and autoimmune thrombocytopenic purpura: Furthermore, to the best of our knowledge, a monkey model of ITP was established for the first time in our study and using this model, we demonstrated that Fc-modified anti-Hp antibody has non-inferior efficacy compared to IVIG at considerably lower doses.